Stay updated on GLPG1205 in IPF: Effective & Safe Clinical Trial
Sign up to get notified when there's something new on the GLPG1205 in IPF: Effective & Safe Clinical Trial page.

Latest updates to the GLPG1205 in IPF: Effective & Safe Clinical Trial page
- Check2 days agoChange DetectedThe record for the completed GLPG1205 Phase 2 study in idiopathic pulmonary fibrosis is displayed, with trial details, participant criteria, study locations, outcome measures, publications, and study documents.SummaryDifference61%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA notice announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs. It appears above the inaccessible study record.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page for NCT03725852 now displays a 403 Forbidden error, replacing the study content and navigation. This access block prevents viewing the study information on that page.SummaryDifference17%

Stay in the know with updates to GLPG1205 in IPF: Effective & Safe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1205 in IPF: Effective & Safe Clinical Trial page.